Natural vitamin e pill may delay liver transplant in cirrhosis patients

NCT ID NCT02581085

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a natural vitamin E supplement called tocotrienol can slow the worsening of end-stage liver disease. Seventy adults with stable but advanced liver disease (MELD score 8–17) will take either tocotrienol or a placebo twice daily for three years. The main goal is to see if the supplement prevents a rise in the MELD score, which measures liver function and predicts transplant need.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Tocotrienol (a natural vitamin E supplement)
What this could lead to
If it works, this could provide a simple, safe supplement to slow liver damage and delay the need for a transplant in people with end-stage liver disease.
What could go wrong
This is a small, early-phase trial (70 people) testing a supplement against a placebo. Previous results need confirmation, and the supplement may not slow disease progression or prevent serious complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IU Health Unviersity Hospital

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.